APA (7th ed.) Citation

Jin, X., Wang, Y., Chen, J., Niu, M., Yang, Y., Zhang, Q., & Bao, G. Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: Structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Jin, Xing, Yuting Wang, Jing Chen, Miaomiao Niu, Yang Yang, Qiaoxuan Zhang, and Guangyu Bao. Novel Dual-targeting Inhibitors of NSD2 and HDAC2 for the Treatment of Liver Cancer: Structure-based Virtual Screening, Molecular Dynamics Simulation, and In vitro and In vivo Biological Activity Evaluations. Taylor & Francis Group.

MLA (9th ed.) Citation

Jin, Xing, et al. Novel Dual-targeting Inhibitors of NSD2 and HDAC2 for the Treatment of Liver Cancer: Structure-based Virtual Screening, Molecular Dynamics Simulation, and In vitro and In vivo Biological Activity Evaluations. Taylor & Francis Group.